First-line chemotherapy plus immunotherapy in biliary tract cancer

被引：3
|
作者：
Neuzillet, Cindy [1 ]
机构：
[1] Paris Saclay Univ, Versailles St Quentin Univ, Curie Inst, Dept Med Oncol, F-92210 St Cloud, France
来源：
LANCET GASTROENTEROLOGY & HEPATOLOGY | 2022年 / 7卷 / 06期
关键词：
D O I：
10.1016/S2468-1253(22)00052-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：496 / 497
页数：2
相关论文
共 50 条
  • [41] Safety and efficacy of GEMOX plus donafenib and tislelizumab as first-line therapy for advanced epithelial malignant biliary tract cancer
    Wang, L.
    Wang, L.
    Zhang, T.
    Zhao, Y.
    Mao, A.
    Zhu, W.
    Zhang, N.
    ANNALS OF ONCOLOGY, 2022, 33 : S288 - S288
  • [42] Phase 2/3 study of bintrafusp alfa with gemcitabine plus cisplatin as first-line treatment of biliary tract cancer
    Oh, Do-Youn
    de Braud, Filippo
    Bridgewater, John
    Furuse, Junji
    Hsu, Chih-Hung
    Ikeda, Masafumi
    Lee, Sunyoung
    Moehler, Markus
    Park, Joon Oh
    Shen, Lin
    Yoo, Changhoon
    Helwig, Christoph
    Osada, Motonobu
    Borad, Mitesh
    ANNALS OF ONCOLOGY, 2021, 32 : S333 - S333
  • [43] ATM Expression as a Prognostic Marker in Patients With Advanced Biliary Tract Cancer Treated With First-line Gemcitabine and Platinum Chemotherapy
    Kim, Hyera
    Kim, Seung Tae
    Yoo, Kwai Han
    Hong, Jung Yong
    Park, Young Suk
    Lim, Ho Yeong
    Park, Joon Oh
    IN VIVO, 2021, 35 (01): : 499 - 505
  • [44] FOLFOX-4 Regimen or Single-agent Gemcitabine as First-line Chemotherapy in Advanced Biliary Tract Cancer
    Novarino, Anna Maria Teresa
    Satolli, Maria Antonietta
    Chiappino, Isabella
    Giacobino, Alice
    Napoletano, Raffaella
    Ceccarelli, Manuela
    Ciccone, Gianni
    Schena, Marina
    Bertetto, Oscar
    Ciuffreda, Libero
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (05): : 466 - 471
  • [45] Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma
    Thongprasert, S
    Napapan, S
    Charoentum, C
    Moonprakan, S
    ANNALS OF ONCOLOGY, 2005, 16 (02) : 279 - 281
  • [46] Prospective Phase II Trial of Gemcitabine in Combination with Irinotecan as First-Line Chemotherapy in Patients with Advanced Biliary Tract Cancer
    Chung, Moon Jae
    Kim, Yoon Jae
    Park, Jeong Youp
    Bang, Seungmin
    Song, Si Young
    Chung, Jae Bock
    Park, Seung Woo
    CHEMOTHERAPY, 2011, 57 (03) : 236 - 243
  • [47] LDH serum levels as prognostic and predictive factor in advanced biliary tract cancer patients treated with first-line chemotherapy
    Faloppi, Luca
    Del Prete, Michela
    Scartozzi, Mario
    Santini, Daniele
    Bianconi, Maristella
    Giampieri, Riccardo
    Cascinu, Stefano
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [48] An estimation of the population survival benefit of first-line chemotherapy and immunotherapy for breast cancer
    Delaney, G. P.
    Do, V.
    Ng, W.
    Barton, M. B.
    CANCER RESEARCH, 2017, 77
  • [49] A phase 2, open-label, safety and efficacy study of telotristat ethyl plus first-line chemotherapy in patients with advanced biliary tract cancer.
    Kim, Richard D.
    Joseph-Ridge, Nancy
    Du, Jichang
    North, Janine
    Warren, Cathy
    Iyer, Renuka V.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 472 - 472
  • [50] New Combinations for the First-line Treatment Biliary Tumors and Liver Cancer: Upswing for Immunotherapy
    Sonnet, Miriam
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 (06)
12345